AU2002334208A1 - 2-aminoquinolone derivatives for use as impdh inhibitors - Google Patents

2-aminoquinolone derivatives for use as impdh inhibitors

Info

Publication number
AU2002334208A1
AU2002334208A1 AU2002334208A AU2002334208A AU2002334208A1 AU 2002334208 A1 AU2002334208 A1 AU 2002334208A1 AU 2002334208 A AU2002334208 A AU 2002334208A AU 2002334208 A AU2002334208 A AU 2002334208A AU 2002334208 A1 AU2002334208 A1 AU 2002334208A1
Authority
AU
Australia
Prior art keywords
aminoquinolone
derivatives
impdh inhibitors
impdh
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002334208A
Inventor
George Martin Buckley
Natasha Davies
Hazel Joan Dyke
Duncan Robert Hannah
Alan Findlay Haughan
Marianna Dilani Richard
Andrew Sharpe
Sophie Caroline Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU2002334208A1 publication Critical patent/AU2002334208A1/en
Abandoned legal-status Critical Current

Links

AU2002334208A 2001-10-23 2002-10-22 2-aminoquinolone derivatives for use as impdh inhibitors Abandoned AU2002334208A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0125365.7 2001-10-23
GB0205372.6 2002-03-07

Publications (1)

Publication Number Publication Date
AU2002334208A1 true AU2002334208A1 (en) 2003-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
AU2003293356A1 (en) Dihydropyridinone derivatives as hne inhibitors
AU2002303892A1 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
SI1686119T1 (en) Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
IL159926A0 (en) Aminoisoxazole derivatives active as kinase inhibitors
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003302238A1 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
AU2003250475A1 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
AU2003239508A1 (en) Indole compounds useful as impdh inhibitors
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003250465A1 (en) 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2003232362A1 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2003273169A1 (en) 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
AU2002953019A0 (en) Azole derivatives